Market Eyes LiveMarket Eyes Live

Merck & Co., Inc. (MRK) Stock Rating

MELANY's data-driven read on Merck & Co., Inc. · Pharmaceutical Preparations.

72/100
BUY
···
Live price

Merck makes pharmaceutical products across several therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, its immuno-oncology platform led by Keytruda is a major sales contributor; it also has a substantial vaccine business targeting pediatric diseases plus Gardasil for human papillomavirus, and it sells animal health drugs. Geographically, 47% of sales come from US human health (pharmaceuticals and vaccines).

Rating as of 2026-07-07. Live price updates in real time.

Create a free account for MRK's full trade plan

Entry zone, stop-loss, price targets, and live alerts unlock when you sign up. No card required.